Trending...
- California: Governor Newsom announces new tax credits that will generate $2.1 billion investment in world's 4th largest economy
- New PSA Campaign to Address Black Maternal and Infant Mortality in Los Angeles County
- EY US unveils Lance Watkins of Tenant Inc. as an Entrepreneur Of The Year® 2025 Pacific Southwest Award finalist
SAN DIEGO - Californer -- Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on The Californer
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on The Californer
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Porta Potty USA Expands its Convenient Portable Restroom Rental Services Business in Louisiana Area
- Miss United Crown of America Launches as a National Platform for Purpose-Driven Titleholders
- Judge Joscelyn Jones Honored with Toastmasters Award for Communication and Leadership Excellence
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Source: Molecular Depot
0 Comments
Latest on The Californer
- Gravity to Bring 5-Minute EV Charging to 8 Sites Across Greater LA
- California: Governor Newsom issues statement on Pope Leo XIV, the first American Pope
- New poll shows high rates of employee burnout amid concerns over politics and personal finances
- Tessellations Appoints Luthern Williams as Head of School
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Psychological Thriller "Killing Off Connor" To Open 34th IFS Film Fest After 12-years In Post
- Harvest Properties Acquires Two San Francisco Bay Area Self Storage Facilities for $44.2 Million
- California businesses in near-universal compliance with prohibition of intoxicating hemp products harmful to youth
- California: Governor Newsom announces upgrades to 21 state fish hatcheries to boost salmon populations
- Solaris Energy Infrastructure, Inc. (SEI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Risk Rater, Threat Assessment App, gives Users the Same Threat Evaluation as the Rich and Powerful
- Is it Really True That Tariffs Will Raise Car Insurance Rates?
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Coastal Business Systems Wraps Up Successful 2025 Tech Show in Redding
- AdOcto Turns AirBnBs Into High-Impact Advertising Channels
- Zefr Announces Launch of Pre-Screen Brand Safety Solution for Google's Search Partner Network (SPN)
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Flexi-View Lending Closes $5.05 Million Residential Acquisition Loan in Billings, Montana
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame